Statistical Characteristics of Moxifloxacin-Induced QTc Effect
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2010/04/06
-
Indian UGC (journal)
-
Refrences6
-
Citations48
-
Lihan K. Yan a Division of Biometrics VI, Office of Biostatistics/Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration , Silver Spring, Maryland, USA
-
Joanne Zhang a Division of Biometrics VI, Office of Biostatistics/Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration , Silver Spring, Maryland, USA
-
Moh Jee Ng a Division of Biometrics VI, Office of Biostatistics/Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration , Silver Spring, Maryland, USA
-
Qianyu Dang a Division of Biometrics VI, Office of Biostatistics/Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration , Silver Spring, Maryland, USA
Cite
Yan, Lihan K., et al. “Statistical Characteristics of Moxifloxacin-Induced QTc Effect”. Journal of Biopharmaceutical Statistics, vol. 20, no. 3, 2010, pp. 497-0, https://doi.org/10.1080/10543400903581945.
Yan, L. K., Zhang, J., Ng, M. J., & Dang, Q. (2010). Statistical Characteristics of Moxifloxacin-Induced QTc Effect. Journal of Biopharmaceutical Statistics, 20(3), 497-507. https://doi.org/10.1080/10543400903581945
Yan, Lihan K., Joanne Zhang, Moh Jee Ng, and Qianyu Dang. “Statistical Characteristics of Moxifloxacin-Induced QTc Effect”. Journal of Biopharmaceutical Statistics 20, no. 3 (2010): 497-507. https://doi.org/10.1080/10543400903581945.
Yan LK, Zhang J, Ng MJ, Dang Q. Statistical Characteristics of Moxifloxacin-Induced QTc Effect. Journal of Biopharmaceutical Statistics. 2010;20(3):497-50.
Journal Categories
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
Science
Mathematics
Probabilities
Mathematical statistics
You May Also Like
- Optimal caliper widths for propensity‐score matching when estimating differences in means and differences in proportions in observational studies
- Sample size of 12 per group rule of thumb for a pilot study
- Guidelines for accurate EC50/IC50 estimation
- Quantifying heterogeneity in a meta‐analysis
- Multiple imputation using chained equations: Issues and guidance for practice
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Analysis of the QT interval and its variability in healthy adults during rest and exercise | 9 | 2006 | ||
| ICH (E14) Guidance. The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Nonantiarrhythmic Drugs | 2005 | |||
| Testing for Positive Control Activity in a Thorough QTc Study | Journal of Biopharmaceutical Statistics |
| 42 | 2008 |
| A Statistical Assessment of QT Data Following Placebo and Moxifloxacin Dosing in Thorough QT Studies | Journal of Biopharmaceutical Statistics |
| 16 | 2008 |
| The Effect of Moxifloxacin on QTc and Implications for the Design of Thorough QT Studies | Clinical Pharmacology & Therapeutics |
| 119 | 2008 |
Citations
Citations Analysis
The category
Medicine: Therapeutics. Pharmacology 33
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Response to Letter to the Editor: Validation Testing in Thorough QT/QTc Clinical Trials by Yi Tsong et al. and was published in 2010. The most recent citation comes from a 2024 study titled QT-Interval Prolongation in the Treatment of Drug-Resistant Tuberculosis. This article reached its peak citation in 2013, with 9 citations. It has been cited in 27 different journals, 22% of which are open access. Among related journals, the British Journal of Clinical Pharmacology cited this research the most, with 6 citations. The chart below illustrates the annual citation trends for this article.